Case Analysis of the Motives and Effects of Mergers and Acquisitions of Listed Companies Taking Liuyao’s Acquisition of Vantone Pharmaceuticals as an Example

Xiaolin Li; Chunyan Lu; Jia Xu; Yuqi Lv

doi:10.2991/978-94-6463-710-6_30

<Previous Article In Volume

Next Article In Volume>

Case Analysis of the Motives and Effects of Mergers and Acquisitions of Listed Companies Taking Liuyao’s Acquisition of Vantone Pharmaceuticals as an Example

Authors

Xiaolin Li¹, Chunyan Lu¹^{, *}, Jia Xu¹, Yuqi Lv¹

¹Business and Tourism School, Sichuan Agricultural University, Chengdu, 611830, China

^*Corresponding author. Email: Luchunyan274@163.com

Corresponding Author

Chunyan Lu

Available Online 14 May 2025.

DOI: 10.2991/978-94-6463-710-6_30 How to use a DOI?
Keywords: M&A drivers; M&A effects; “PE+ listed companies” M&A methods
Abstract: Since the outbreak of the COVID-19 pandemic at the end of 2019, the pharmaceutical industry has entered a period of rapid development. Enterprises have adjusted resources through mergers and acquisitions to achieve scale expansion and synergy effects, thereby enhancing their strength. This paper analyzes the case of Liuzhou Pharmaceutical Co., Ltd.’s acquisition of Wantong Pharmaceutical in 2018, quantitatively examines various financial indicators from 2014 to 2019, explores the feasible paths for the future development of small and medium-sized pharmaceutical companies, and explores the specific motives and effects of mergers and acquisitions by listed companies through the “PE + listed company” type of merger and acquisition approach, providing a reference for optimizing merger and acquisition strategies.
Copyright: © 2025 The Author(s)
Open Access: Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume

Next Article In Volume>

Volume Title: Proceedings of the 2025 4th International Conference on Big Data Economy and Digital Management (BDEDM 2025)
Series: Advances in Intelligent Systems Research
Publication Date: 14 May 2025
ISBN: 978-94-6463-710-6
ISSN: 1951-6851
DOI: 10.2991/978-94-6463-710-6_30 How to use a DOI?
Open Access: Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

ris enw bib

TY  - CONF
AU  - Xiaolin Li
AU  - Chunyan Lu
AU  - Jia Xu
AU  - Yuqi Lv
PY  - 2025
DA  - 2025/05/14
TI  - Case Analysis of the Motives and Effects of Mergers and Acquisitions of Listed Companies Taking Liuyao’s Acquisition of Vantone Pharmaceuticals as an Example
BT  - Proceedings of the 2025 4th International Conference on Big Data Economy and Digital Management (BDEDM 2025)
PB  - Atlantis Press
SP  - 256
EP  - 263
SN  - 1951-6851
UR  - https://doi.org/10.2991/978-94-6463-710-6_30
DO  - 10.2991/978-94-6463-710-6_30
ID  - Li2025
ER  -

download .riscopy to clipboard